Interim / Quarterly Report • Jun 30, 2013
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
Interim Report for the 6 months ended 30 June 2013
Company Number: 4084003
The Company's Total Return has increased by 2.3 pence per ordinary share from 100.0 pence to 102.3 pence per ordinary share as at 31 December 2012. This includes cumulative dividends paid of 37.0 pence per ordinary share.
Your Company continues to make progress with an overall increase in Net Asset Value ("NAV") of 3.5 per cent prior to the payment of dividends totalling 2.5 pence per ordinary share.
The underlying value growth in the Company's investment portfolio was £1.1 million, representing a 9.7 per cent increase over the past 6 months.
A final dividend of 2.5 pence per ordinary share in respect of the year ended 31 December 2012 (year ended 31 December 2011: 2.0 pence per ordinary share) was paid on 5 June 2013, of which 15 per cent was re-invested via the Company's Dividend Re-investment Scheme. This brings cumulative dividends paid since the Company's inception to 37.0 pence per ordinary share.
The Board has proposed an interim dividend of 2.0 pence in respect of the period to 30 June 2013 maintaining the underlying dividend stream generated over the last 12 months. The average dividend over the last five years is 5.0 pence per ordinary share: representing a yield of 7.7 per cent on the NAV at 30 June 2013.
| Financial Highlights | 2 |
|---|---|
| Financial Summary | 3 |
| Financial Calendar | 3 |
| Business Review | |
| Chairman's Statement | 4 |
| Investment Portfolio | 7 |
| Top 15 Investments | 10 |
| Unaudited Statement of | |
|---|---|
| Comprehensive Income | 14 |
| Unaudited Balance Sheet | 15 |
| Unaudited Statement of Changes in Equity | 16 |
| Unaudited Statement of Cash Flows | 18 |
| Notes to the Unaudited | |
| Financial Statements | 19 |
| Advisers to the Company | 23 |
For the 6 months ended 30 June 2013
The chart below shows how the Total Return of your Company, calculated by reference to the Net Asset Value per ordinary share plus cumulative dividends paid per ordinary share has developed over the last five years.
Results Announced 21 August 2013 Ex-Dividend Date 28 August 2013 Record Date 30 August 2013 DRIS Election Date 13 September 2013 Dividend Paid 27 September 2013
I am pleased to report a strong performance for your Company. In the six months to 30 June 2013 the Company has seen an increase in Net Asset Value of 3.5 per cent per ordinary share before the payment of the 2.5 pence per ordinary share final dividend. This growth was generated primarily from an increase in valuations across the unquoted investment portfolio.
In April 2013 the Company completed a successful joint fundraising with British Smaller Companies VCT plc, raising net proceeds of £3.3 million in the six months to June 2013 (£5.4 million since its launch in November 2012).
In the six months since 31 December 2012 the Total Return, calculated by reference to Net Asset Value plus cumulative dividends, has increased by 2.3 pence per ordinary share.
The chart on page 2 shows in greater detail the movement in Total Return and dividends paid over time.
The Net Asset Value per ordinary share grew by 2.3 pence to 67.8 pence in the last six months
prior to the payment of the final dividend of 2.5 pence per ordinary share, giving a net reduction in the Net Asset Value per ordinary share of 0.2 pence, shown in the table below.
I am particularly pleased to note that, of the final dividend of 2.5 pence per ordinary share paid in June 2013, over 15 per cent was re-invested via the Company's Dividend Re-investment Scheme.
The net gain on the investment portfolio was £1.10 million, representing a 2.4 pence per ordinary share increase in Net Asset Value, and an increase of 9.7 per cent on the opening December 2012 portfolio value of £11.4 million. This is made up of an 11.8 per cent increase from the unquoted investments and a 1.5 per cent increase from quoted securities.
| Pence/ordinary share | |
|---|---|
| 31 December 2012 | 65.5 |
| Net increase in portfolio | 2.4 |
| Other decrease in value | (0.2) |
| Net increase in value | 2.2 |
| Buy back of shares | 0.1 |
| Dividends paid in period | (2.5) |
| 30 June 2013 | 65.3 |
The Company currently has an active portfolio of 26 investments, 16 of which are unquoted and the remainder are quoted on AIM. At 30 June 2013 the investment portfolio had a value of £12.38 million consisting of £10.35 million (83.6 per cent) in the unquoted portfolio and £2.03 million (16.4 per cent) in the AIM portfolio.
Good progress has been made across the portfolio with profit growth despite the continued low growth economic environment. The most significant movements in valuations were DisplayPlan Holdings Limited (increase of £0.33 million), Bluebell Telecom Group Limited (increase of £0.19 million), Seven Technologies Holdings Limited (increase of £0.14 million), and Waterfall Services Limited (increase of £0.12 million).
In the 6 months to 30 June 2013 the Company has completed one new investment and two follow on investments totalling £0.95 million. The details of which are set out below:
Since 30 June 2013 an additional £0.58 million has been invested, of which £0.38 million was invested to support the refinancing and roll out of bakery and retail chain Bagel Nash Group Limited, an existing portfolio company, with the remaining £0.2 million invested in existing AIM listed portfolio comany Hargreaves Services plc.
During the six months to 30 June 2013 the Company received proceeds from disposals, repayments of loans and deferred consideration of £1.15 million which resulted in a small gain on disposal of investments of £0.01 million.
The most significant contributor to this was a loan repayment of £0.70 million as part of a refinancing package into Seven Technologies Holdings Limited ahead of its purchase of Datong plc.
The Company also realised three of its AIM investments over the period: Tikit Group plc, May Gurney Integrated Services plc and 2ergo Group plc, generating proceeds of £0.36 million, and a gain over the 31 December 2012 valuation of £0.01 million.
Deferred consideration of £0.09 million in respect of the trade sale of DxS Limited in 2009 was received. This brings total returns from this investment to £2.73 million, representing a multiple of 16.7x on capital invested.
Following 30 June 2013 the Company realised its investment in healthcare software provider Digital Healthcare Limited via a trade sale to Emis Group plc realising proceeds of £1.26 million, an increase over the 30 June 2013 valuation of £0.24 million. The Company also part realised its investment in Pressure Technologies plc generating proceeds of £0.1 million.
Your Board remains committed to achieving the objective of a constant and increasing dividend stream over time. Following the 2012 year end a dividend of 2.5 pence was paid on 5 June 2013. This commitment has been continued in these interim results and your Board is pleased to announce an interim dividend of 2.0 pence per ordinary share, to be paid on 27 September 2013 to Shareholders on the register at 30 August 2013.
Following the success of the Company's 18th Shareholder workshop in February 2013, the Company is pleased to announce that its next workshop will be held at The Central Hall, Westminster, London on 12 February 2014.
Following the joint offer for subscription with British Smaller Companies VCT plc, published on 19 November 2012, your Board is pleased to announce the offer was fully subscribed and raised a total of £5.37 million net of costs. This leaves the Company well placed to take advantage of the recent changes to UK legislation which has increased the maximum amount VCTs are able to invest in any one company to £5 million per year.
The last six months have seen the continuation of the low economic growth conditions of recent years. Despite this many of the portfolio companies have delivered improved results building on their performances of recent years.
The current pipeline of new investment opportunities remains strong and has been increasing, although the timescales to convert from opportunity to investment are significant. The changes in EU restrictions on qualifying investments, which include increasing the amount that can be invested into a business to £5 million in any one year, should also lead to an increase in the volume and scale of investment opportunities for the Company in the future.
The Board continues to be of the opinion that the forthcoming period will see many good investment opportunities, both for the portfolio businesses and for new investments. It was with this in mind that we increased the investment capacity of the Company and we will consider reviewing the need to increase funds further as the pipeline of investment opportunities is converted.
There has been no change to the principal risks and uncertainties facing the Company since the publication of the financial statements for the year ended 31 December 2012. In summary, the principal risks are:
Full details of the principal risks can be found in the financial statements for the year ended 31 December 2012 on pages 29 and 30, a copy of which is available at www.yfmep.com
Richard Last Chairman 21 August 2013
| Name of Company | Date of Initial Investment |
Industry Sector |
Current £000 |
Realised Cost* Proceeds to Date £000 |
Investment Valuation at 30 June 2013 £000 |
Realised and Unrealised to Date £000 |
% of Equity held by BSC VCT2 plc |
% of Equity held by all Funds** |
|---|---|---|---|---|---|---|---|---|
| CURRENT INVESTMENTS Unquoted portfolio |
||||||||
| DisplayPlan Holdings Limited | Jan-12 | Retail | 700 | – | 1,834 | 1,834 | 12.25 | 35.00 |
| Seven Technologies Holdings | ||||||||
| Limited | May -12 | Manufacturing | 1,238 | 762 | 1,376 | 2,138 | 6.30 | 38.12 |
| Digital Healthcare Limited | Jun-05 | Medical Instruments | 3,072 | – | 1,016 | 1,016 | 25.04 | 25.04 |
| Deep-Secure Ltd | Dec-09 | Security Software | 500 | – | 999 | 999 | 7.15 | 50.00 |
| Immunobiology Limited | Jun-03 | Pharmaceuticals | 1,932 | – | 987 | 987 | 23.44 | 23.44 |
| Insider Technologies | ||||||||
| (Holdings) Limited | Aug-12 | Software | 780 | – | 817 | 817 | 17.20 | 43.00 |
| Bluebell Telecom Group Limited | Sep-10 | Telecommunications | 500 | – | 708 | 708 | 6.75 | 13.50 |
| PowerOasis Limited | Nov-11 | Energy Infrastructure | 567 | – | 567 | 567 | 2.40 | 12.10 |
| Waterfall Services Limited | Feb-07 | Food Services | 192 | 292 | 503 | 795 | 4.88 | 24.41 |
| Harvey Jones Holdings Limited Bagel Nash Group Limited |
May-07 Jul-11 |
Consumer Retail Retail Bakery |
389 422 |
– – |
441 400 |
441 400 |
3.44 4.60 |
30.12 40.00 |
| Selima Limited | Mar-12 | Payroll Software | 300 | – | 337 | 337 | 6.25 | 18.75 |
| RMS Group Holdings Limited | Jul-07 | Industrial Services | 70 | 338 | 302 | 640 | 3.15 | 31.50 |
| Tissuemed Limited | Dec-05 | Healthcare | 48 | – | 60 | 60 | 1.63 | 1.63 |
| Ellfin Home Care Limited | Dec-07 | Healthcare | 317 | – | 5 | 5 | 6.17 | 73.98 |
| TeraView Limited | Dec-11 | Medical Instruments | 375 | – | – | – | 7.50 | 15.00 |
| Total Unquoted | 11,402 | 1,392 | 10,352 | 11,744 | ||||
| Quoted portfolio | ||||||||
| Iomart Group plc | May-11 | Internet Services | 148 | 112 | 450 | 562 | 0.17 | 0.17 |
| Pressure Technologies plc | Jun-07 | Manufacturing | 300 | – | 380 | 380 | 1.76 | 4.26 |
| EKF Diagnostics Holdings plc | Jun-11 | Pharmaceuticals | 224 | – | 235 | 235 | 0.33 | 0.90 |
| AB Dynamics plc | May-13 | Manufacturing | 149 | – | 206 | 206 | 1.06 | 2.65 |
| Vianet Group plc (formerly Brulines Group plc) |
Oct-06 | Electronics | 243 | – | 161 | 161 | 0.79 | 2.09 |
| Brady plc | Dec-10 | Commodities Software | 134 | 163 | 159 | 322 | 0.28 | 0.28 |
| Cambridge Cognition Limited | May-02 | Medical Software | 240 | – | 159 | 159 | 1.19 | 3.28 |
| Hargreaves Services plc | Aug-12 | Industrial | 125 | – | 138 | 138 | 0.06 | 0.34 |
| Optos plc | Dec-05 | Medical Instruments | 81 | 167 | 90 | 257 | 0.11 | 0.11 |
| Allergy Therapeutics plc | Oct-04 | Biotechnology | 350 | – | 47 | 47 | 0.11 | 0.11 |
| Total Quoted | 1,994 | 442 | 2,025 | 2,467 | ||||
| Total Portfolio | 13,396 | 1,834 | 12,377 | 14,211 | ||||
| Investments realised to date | 11,777 | 18,751 | – | 18,751 | ||||
| Total realised and unrealised to date | 25,173 | 20,585 | 12,377 | 32,962 |
* Original or acquired cost where the investment was acquired at the fair value ascribed to it at the time of the acquisition of British Smaller Technology Companies VCT plc.
** All funds managed by the Fund Manager within YFM Private Equity Limited including British Smaller Companies VCT2 plc.
| Name of Company | Date of Initial Investment |
Industry Sector |
Original Cost* |
Proceeds to Date |
Capital Return Multiple |
Gain (Losses) on Disposal |
|---|---|---|---|---|---|---|
| £000 | £000 | X | £000 | |||
| REALISED INVESTMENTS | ||||||
| DxS Limited | Apr-04 | Healthcare | 163 | 2,726 | 16.72 | 2,563 |
| Sarian Systems Limited | Dec-05 | Telecoms | 928 | 2,605 | 2.80 | 1,677 |
| Amino Technologies plc | Sep-01 | Electronics | 415 | 1,875 | 4.52 | 1,460 |
| Cozart plc | Jul-04 | Healthcare | 1,566 | 2,983 | 1.90 | 1,417 |
| Vibration Technology Limited | Mar-02 | Industrial | 1,061 | 2,328 | 2.20 | 1,267 |
| Primal Pictures Limited | Dec-05 | Medical Software | 897 | 2,005 | 2.24 | 1,108 |
| Sirigen Group Limited | Oct-10 | Medical Diagnostics | 517 | 1,446 | 2.80 | 929 |
| The ART Technology Group Inc | Apr-03 | Software | 275 | 638 | 2.32 | 363 |
| Tamesis Limited | Jul-01 | Software | 150 | 317 | 2.11 | 167 |
| Voxar Limited | Dec-05 | Software | – | 134 | – | 134 |
| Tekton Group Limited | Dec-05 | Software | 100 | 223 | 2.23 | 123 |
| Arakis Limited | Mar-04 | Healthcare | 14 | 108 | 7.71 | 94 |
| Tikit Group plc | Jun-11 | Legal Services Software | 198 | 279 | 1.53 | 81 |
| Hallco 1389 Limited & Hallco 1390 Limited | Dec-06 | Software | 50 | 126 | 2.52 | 76 |
| Group NBT plc | May-11 | Internet Services | 197 | 256 | 1.30 | 59 |
| Oxonica plc | May-02 | Chemical | 241 | 258 | 1.07 | 17 |
| Intelligent Recording Limited | Sep-08 | Electronics | – | – | – | – |
| Solcom Limited | Dec-05 | Software | – | – | – | – |
| Oxis Energy Limited | Dec-05 | Electronics | 5 | 4 | (1) | (1) |
| SoseiCo Limited | Aug-05 | Healthcare | 158 | 94 | 0.59 | (64) |
| May Gurney Integrated Services plc | Jun-11 | Maintenance Services | 212 | 141 | 0.67 | (71) |
| Patsystems plc | Oct-07 | Healthcare | 317 | 164 | 0.52 | (153) |
| 2ergo Group plc | May-11 | Marketing Services | 197 | 3 | 0.02 | (194) |
| Sirus Pharmaceuticals Limited | Sep-01 | Healthcare | 270 | 14 | 0.05 | (256) |
| Infinite Data Storage Limited | Mar-02 | Software | 425 | – | – | (425) |
| Purely Proteins Limited | Nov-03 | Software | 438 | – | – | (438) |
| ExpressOn Biosystems Limited | Oct-02 | Healthcare | 450 | – | – | (450) |
| Broadreach Networks Limited | Feb-03 | Telecoms | 550 | 17 | 0.03 | (533) |
| Comvurgent Limited | Dec-05 | Software | 611 | – | – | (611) |
| Focus Solutions Group plc | Dec-05 | Software | 7 | 7 | 1 | – |
| Silistix Limited | Dec-03 | Electronics | 1,365 | – | – | (1,365) |
| Investments realised to date | 11,777 | 18,751 | – | 6,974 |
* Original or acquired cost where the investment was acquired at the fair value ascribed to it at the time of the acquisition of British Smaller Technology Companies VCT plc.
Manufacturing and Industrial Services Retail and Brands
IT and Telecommunications
Healthcare Business Services
Baldock, Herts www.displayplan.com
In January 2012 an investment was made to support the management buy-out of DisplayPlan Holdings, a company providing a complete retail display consultancy service from concept through design and sourcing to finished product delivery to established branded product manufacturers and UK retailers. Typical products include bespoke point of purchase (POP) stands in high street retail stores and the business enjoys regular repeat work from a long-established customer base.
County Antrim www.seventechnologies.co.uk
www.digital-healthcare.co.uk
Cambridge
Seven Technologies is a fast growing specialist engineering business based in Northern Ireland specialising in the development and manufacture of bespoke electronics and communications applications for operation in inhospitable environments. The strategy is to maintain the impressive expansion to date through increasing the company's international presence and significantly growing average contract sizes, in what is now a significant international market for its products.
Digital Healthcare has developed software for the management of digital images in the diabetic screening, ophthalmology and optometric markets. It has developed its UK business becoming a leading supplier of diabetic retinopathy screening software to the NHS. Following 30 June 2013, the Company sold its shareholding generating proceeds of £1.26 million, giving rise to a gain of £0.24 million over its previous valuation.
Deep-Secure's market leading products protect against threats to IT security via high security network border gateway technology, which enables customers to maintain network separation and apply content inspection so as to defend sensitive and protected information from intruders. As working practices change and more information is shared electronically, increasing levels of exposure to leakage and attack demands more businesses rely on higher levels of security to protect their data, with main customers being international governments, cross border forces and defence sectors. Profit levels have grown strongly since the Company's investment in 2009.
Immunobiology has developed a new platform technology to produce high efficacy vaccines for infectious diseases including influenza, tuberculosis, meningitis and hepatitis. A licence deal has recently been signed with Chinese pharmaceutical group Lanzhou Institute of Biological Products Co Limited to fund the clinical development of a TB vaccine in China. Regulatory clearance has also been granted to commence human trials for universal meningitis vaccine and a £3.0 million funding round was closed in August 2012.
Insider Technologies is an established provider of monitoring and scheduling software to the financial services and national security sectors. The Company backed the buyout of the business introducing new senior management to complement the existing team, who also invested in the deal. The strategy is to increase the sales focus and roll out existing and new complementary products in the UK and overseas.
Bluebell is a telecommunications service provider that aggregates a range of services including fixed line, mobile and data to UK businesses. The Company's investment was made to assist with the next phase of Bluebell's growth. In August 2011 Bluebell acquired another telecommunications group Worldwide ISDN Limited which has now been successfully integrated.
Manchester www.insidertech.co.uk
Cambridge www.immbio.com
Newcastle-upon-Tyne www.bluebelltelecom.com
PowerOasis is a leader in power management and energy efficient solutions for wireless operators. It has developed an innovative wireless network power management software platform that remotely monitors, controls and manages the supply of power to base station sites that lack a reliable electricity grid in the Middle East and Africa. PowerOasis is an energy partner for two of the world's largest network equipment providers and some of the world's largest mobile telecom operators, which use PowerOasis technology to reduce the operating cost of power while significantly improving network availability. A further \$5 million funding round was completed in February 2013 which included a significant investment from a trade partner.
Warrington www.caterplus.co.uk
Waterfall is a contract caterer specialising in the care home sector. Since the original investment in 2007 the company has expanded its original catering services business from supplying residential and care homes to supplying the educational market. There has been both organic and acquisitive growth which has broadened and diversified the customer base with significant progress being made in expanding the services provided to both the education and care home sectors.
London www.harveyjones.com
Harvey Jones is a manufacturer/retailer of kitchen furniture. The business has a manufacturing facility in the UK and stores in London and affluent provincial towns and cities principally in the South of England. Its strong brand positioning has helped Harvey Jones to retain volumes through the economic downturn. The business has continued to selectively open new stores increasing its footprint to 26 from 10 at the time of investment. This increased market share coupled with a low level of gearing positions Harvey Jones well to benefit as market conditions improve.
Iomart Group is one of Europe's leading providers of managed hosting and cloud computing services. Iomart Group specialises in the design, delivery and management of business-critical hosting services enabling companies and organisations to reduce the cost, complexity and risks associated with maintaining their own web and online applications. The company is following a consolidation strategy in this fragmented and growing market.
Pressure Technologies was admitted to AIM in June 2007. It specialises in the manufacture of ultra-large high pressure cylinders for the offshore oil and gas industry but is increasingly diversifying through acquisitions into other sectors, such as biogas and defence. The balance sheet remains ungeared with substantial cash available.
EKF is a provider of a wide range of diagnostic needs in clinical care, blood donor services and dialysis centres, recreation institutes, sports medicine and industrial applications. EKF's name consists of the first three letters of Geman words, Entwicklung (development), Konstruktion (construction) and Fertigung (production), which are the main business divisions. EKF is well funded and has made some good acquisitions and commercial progress.
AB Dynamics is based in the South West. ABD is engaged in the design, manufacture and supply to the global automotive industry of advanced testing and measurement products for vehicle suspension, brakes and steering both in the laboratory and on the test track. The Group's products are used by the research and development divisions of some of the leading vehicle manufacturers, including Ford, Toyota, Daimler, BMW, VW and Honda.
Vianet Group is the leading provider of volume and revenue protection systems for draught alcoholic drinks for the UK licenced on-trade. The company has consolidated its market leading position and continues to seek to expand its service and product offering. Dividend yield remains strong, but the pub chains continue to struggle, leading Vianet to diversify into related markets, such as petrol forecourts and vending solutions.
British Smaller Companies VCT2 plc 13
Glasgow www.iomart.com
Sheffield
www.pressuretechnologies.com
London www.ekfdiagnostics.com
Stockton-on-Tees www.vianetplc.com
Wiltshire www.abd.uk.com
For the 6 months ended 30 June 2013
| Notes | Unaudited 6 months ending 30 June 2013 |
Unaudited 6 months ending 30 June 2012 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue £000 |
Capital £000 |
Total £000 |
Revenue £000 |
Capital £000 |
Total £000 |
|||||
| Gain on disposal of investments | – | 9 | 9 | – | 76 | 76 | ||||
| Gains on investments held | ||||||||||
| at fair value | – | 1,097 | 1,097 | – | 876 | 876 | ||||
| Income | 2 | 365 | – | 365 | 258 | – | 258 | |||
| Administrative expenses: | ||||||||||
| Fund management fee | (68) | (204) | (272) | (50) | (150) | (200) | ||||
| Other expenses | (168) | – | (168) | (161) | – | (161) | ||||
| (236) | (204) | (440) | (211) | (150) | (361) | |||||
| Profit before taxation | 129 | 902 | 1,031 | 47 | 802 | 849 | ||||
| Taxation | 3 | – | – | – | – | – | – | |||
| Profit for the period | 129 | 902 | 1,031 | 47 | 802 | 849 | ||||
| Total comprehensive income for the period attributable to equity Shareholders |
129 | 902 | 1,031 | 47 | 802 | 849 | ||||
| Basic and diluted earnings per | ||||||||||
| ordinary share | 5 | 0.30p | 2.06p | 2.36p | 0.13p | 2.24p | 2.37p |
The Total column of this statement represents the Company's Statement of Comprehensive Income, prepared in accordance with International Financial Reporting Standards as adopted by the European Union. The supplementary Revenue and Capital columns are prepared under the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' ('SORP') 2009 published by the Association of Investment Companies.
In May 2012 the Association of Investment Companies (AIC) replaced the Total Expense Ratio (TER%) it publishes with the "on-going charges percentage", calculated as the annual on-going charges (excluding irrecoverable VAT, performance fees and trail commission) over average undiluted Net Asset Value in the period. As at 30 June 2013, this benchmark (annualised) is currently 2.7 per cent (30 June 2012: 2.8 per cent). No performance fees have been paid in the current or previous period, and thus no adjusted figure including such fees has been presented.
In order to provide Shareholders with comparable data to prior periods and to assist understanding of the fund management agreement in place the Company has chosen to also disclose the TER%. This is calculated as the annual on-going charges (excluding trail commission and irrecoverable VAT) over Total Net Assets as at the relevant period end and is currently capped at 3.25 per cent, whereby excess costs over this value are absorbed by the Fund Manager. The annualised TER% as at 30 June 2013 is 2.6 per cent (30 June 2012: 2.5 per cent).
As at 30 June 2013
| Notes | Unaudited 6 months ended 30 June 2013 £000 |
Unaudited 6 months ended 30 June 2012 £000 |
Audited year ended 31 December 2012 £000 |
|
|---|---|---|---|---|
| Assets Non-current assets Investments Fixed income government securities |
12,377 901 |
13,044 918 |
11,363 912 |
|
| Financial assets at fair value through profit or loss Trade and other receivables |
13,278 108 |
13,962 68 |
12,275 198 |
|
| Current assets Trade and other receivables Cash on fixed term deposits Cash and cash equivalents |
13,386 114 3,500 13,393 |
14,030 315 – 12,085 |
12,473 423 7,048 7,484 |
|
| Liabilities Current liabilities Trade and other payables |
17,007 (135) |
12,400 (426) |
14,955 (276) |
|
| Net current assets | 16,872 | 11,974 | 14,679 | |
| Net assets | 30,258 | 26,004 | 27,152 | |
| Shareholders' equity Share capital Share premium account Capital redemption reserve Merger reserve Other reserve Capital reserve Investment holding losses Special reserve Revenue reserve |
4,800 4,835 88 5,525 2 285 (2,149) 16,743 129 |
3,942 12,993 88 5,525 2 2,120 (2,778) 4,112 – |
4,271 14,806 88 5,525 2 3,154 (4,919) 4,071 154 |
|
| Total Shareholders' equity | 30,258 | 26,004 | 27,152 | |
| Net Asset Value per ordinary share | 6 | 65.3p | 68.0p | 65.5p |
Signed on behalf of the Board
Richard Last Chairman 21 August 2013
For the six months ended 30 June 2013
| Share capital |
Share premium account |
Merger reserve |
*Other reserves |
reserve | Capital Investment holding gains (losses) reserve |
Special reserve |
Revenue reserve |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|
| £000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
| At 31 December 2011 | 2,426 | 4,427 | 5,525 | 90 | 2,630 | (3,665) | 4,255 | 294 | 15,982 |
| Revenue return | |||||||||
| for the period | – | – | – | – | – (150) |
– | – | 47 | 47 (150) |
| Capital expenses Investment holding |
– | – | – | – | – | – | – | ||
| loss on investments | |||||||||
| held at fair value | – | – | – | – | – | 876 | – | – | 876 |
| Realisation of investments | 76 | 76 | |||||||
| in the period | – | – | – | – | – | – | – | ||
| Total comprehensive | |||||||||
| income for the period | – | – | – | – | (74) | 876 | – | 47 | 849 |
| Issue of share capital | 1,514 | 9,149 | – | – | – | – | – | – | 10,663 |
| Issue of shares – DRIS Issue costs |
2 | 11 (594) |
– | – | – | – | – | – | 13 (594) |
| Purchase of own shares | – – |
– | – – |
– – |
– – |
– – |
– (143) |
– – |
(143) |
| Dividends | – | – | – | – | (425) | – | – | (341) | (766) |
| Total transactions | |||||||||
| with Shareholders | 1,516 | 8,566 | – | – | (425) | - | (143) | (341) | 9,173 |
| Realisation of prior year | |||||||||
| investment holding losses | – | – | – | – | (11) | 11 | – | – | – |
| At 30 June 2012 | 3,942 | 12,993 | 5,525 | 90 | 2,120 | (2,778) | 4,112 | – | 26,004 |
| Revenue return for | |||||||||
| the period | – | – | – | – | – | – | – | 107 | 107 |
| Capital expenses Investment holding gain |
– | – | – | – | (192) | – | – | – | (192) |
| on investments held at | |||||||||
| fair value | – | – | – | – | – | (1,498) | – | – | (1,498) |
| Gain on disposal of | |||||||||
| investments in the period | – | – | – | – | 1,586 | – | – | – | 1,586 |
| Total comprehensive | |||||||||
| income for the period | – | – | – | – | 1,394 | (1,498) | – | 107 | 3 |
| Issue of share capital | 314 | 1,866 | – | – | – | – | – | – | 2,180 |
| Issue costs | – | (132) | – | – | – | – | – | – | (132) |
| Purchase of own shares Issue of shares – DRIS |
– 15 |
– 79 |
– | – | – | – | (41) | – | (41) 94 |
| Dividends | – | – | – – |
– – |
– (1,003) |
– – |
– – |
– 47 |
(956) |
| Total transactions with Shareholders |
329 | 1,813 | – | – | (1,003) | – | (41) | – | 1,145 |
| Realisation of prior year | |||||||||
| investment holding gains | – | – | – | – | 537 | (537) | – | – | – |
| Realisation of negative | |||||||||
| goodwill | – | – | – | – | 106 | (106) | – | – | – |
| At 31 December 2012 | 4,271 | 14,806 | 5,525 | 90 | 3,154 | (4,919) | 4,071 | 154 | 27,152 |
| Share capital |
Share premium account |
Merger reserve |
*Other reserves |
reserve | Capital Investment holding gains (losses) reserve |
Special reserve |
Revenue reserve |
Total equity |
|
|---|---|---|---|---|---|---|---|---|---|
| £000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
| At 31 December 2012 | 4,271 | 14,806 | 5,525 | 90 | 3,154 | (4,919) | 4,071 | 154 | 27,152 |
| Revenue profit | |||||||||
| for the period | – | – | – | – | – | – | – | 129 | 129 |
| Capital expenses Investment holding |
– | – | – | – | (204) | – | – | – | (204) |
| gain on investments held at fair value Gain on disposal |
– | – | – | – | – | 1,097 | – | – | 1,097 |
| of investments in the period |
– | – | – | – | 9 | – | – | – | 9 |
| Total comprehensive income for the period |
– | – | – | – | (195) | 1,097 | - | 129 | 1,031 |
| Issue of ordinary | |||||||||
| share capital | 504 | 2,964 | – | – | – | – | – | – | 3,468 |
| Issue of shares – DRIS Issue costs of |
25 | 130 | – | – | – | – | – | – | 155 |
| ordinary shares | – | (160) | – | – | – | – | – | – | (160) |
| Purchase of own shares | – | – | – | – | – | – | (224) | – | (224) |
| Dividends Cancellation of |
– | – | – | – | (1,001) | – | – | (154) | (1,155) |
| Share Premium | – | (12,905) | – | – | – | – | 12,896 | – | (9) |
| Total transactions with Shareholders |
529 | (9,971) | – | – | (1,001) | – | (12,672) | (154) | 2,075 |
| Realisation of prior year investment holding losses |
– | – | – | – | (1,673) | 1,673 | – | – | – |
| At 30 June 2013 | 4,800 | 4,835 | 5,525 | 90 | 285 | (2,149) | 16,743 | 129 | 30,258 |
* Other reserves include the capital redemption reserve and treasury reserve, which are non-distributable.
For the six months ended 30 June 2013
| Unaudited 6 months |
Unaudited 6 months |
Audited year |
|
|---|---|---|---|
| ended | ended | ended | |
| 30 June | 30 June | 31 December | |
| 2013 £000 |
2012 £000 |
2012 £000 |
|
| Net cash inflow (outflow) from operating activities | 90 | 17 | (354) |
| Cash flows from investing activities | |||
| Purchase of financial assets at fair value through profit or loss | (954) | (2,467) | (4,867) |
| Proceeds from sale of financial assets at fair value through | |||
| profit or loss | 1,062 | 1,238 | 5,239 |
| Cash placed on fixed term deposit | – | – | (7,048) |
| Cash maturing on fixed term deposit | 3,548 | – | – |
| Deferred consideration | 90 | 48 | 99 |
| Net cash from (used in) investing activities | 3,746 | (1,181) | (6,577) |
| Cash flows from financing activities | |||
| Issue of ordinary shares | 3,412 | 10,663 | 12,743 |
| Cost of ordinary shares | (106) | (594) | (605) |
| Purchase of own shares | (224) | (143) | (184) |
| Dividends paid | (1,000) | (753) | (1,615) |
| Share Premium Cancellation costs | (9) | – | – |
| Net cash from financing activities | 2,073 | 9,173 | 10,339 |
| Net increase in cash and cash equivalents | 5,909 | 8,009 | 3,408 |
| Cash and cash equivalents at the beginning of the period | 7,484 | 4,076 | 4,076 |
| Cash and cash equivalents at the end of the period | 13,393 | 12,085 | 7,484 |
These half year statements have been approved by the directors whose names appear at note 8, each of whom has confirmed that to the best of his knowledge:
The half year statements are unaudited and have not been reviewed by the auditors pursuant to the Auditing Practices Board (APB) guidance on Review of Interim Financial Information. They do not constitute full financial statements as defined in section 435 of the Companies Act 2006. The comparative figures for the year ended 31 December 2012 do not constitute full financial statements and have been extracted from the Company's financial statements for the year ended 31 December 2012. Those accounts were reported upon without qualification by the auditors and have been delivered to the Registrar of Companies.
The accounting policies and methods of computation followed in the half year statements are the same as those adopted in the preparation of the audited financial statements for the year ended 31 December 2012.
The financial statements for the year ended 31 December 2012 were prepared in accordance with the International Financial Reporting Standards (IFRSs) as adopted by the European Union and those parts of the Companies Act 2006 applicable to companies reporting under IFRS. Where guidance set out in the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' issued by the Association of Investment Companies in January 2009 ("SORP") is consistent with the requirements of IFRS, the financial statements have been prepared in compliance with the recommendations of the SORP.
Other standards and interpretations have been issued which will be effective for future reporting periods but have not been adopted early in these financial statements. These include the new standards IFRS10, IFRS12 and IFRS13 in addition to amendments to IFRS 1, IFRS 7, IFRS 9, IAS 1, IAS 19, IAS 27, IAS 28 and IAS 32. A full impact assessment has not yet been completed in order to assess whether these new standards will have a material impact on the financial statements.
Going Concern: The directors have carefully considered the issue of going concern and are satisfied that the Company has sufficient resources to meet its obligations as they fall due for a period of at least twelve months from the date these half year statements were approved. As at 30 June 2013 the Company held cash balances, investments in fixed income government securities and fixed term deposits with a combined value of £17,794,000. Cash flow projections show the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of share buy-backs and the dividend policy. The directors therefore believe that it is appropriate to continue to apply the going concern basis of accounting in preparing these half year statements.
| Unaudited 6 months ended 30 June 2013 £000 |
Unaudited 6 months ended 30 June 2012 £000 |
|
|---|---|---|
| Income from investments | ||
| – Dividends from unquoted companies | 28 | 3 |
| – Dividends from AIM quoted companies | 22 | 22 |
| 50 | 25 | |
| – Interest on loans to unquoted companies | 187 | 147 |
| – Fixed interest Government securities | 10 | 11 |
| Income from investments held at fair value through profit or loss | 247 | 183 |
| Interest on bank deposits | 118 | 75 |
| 365 | 258 |
| Unaudited 6 months ended 30 June 2013 |
Unaudited 6 months ended 30 June 2012 |
|||||
|---|---|---|---|---|---|---|
| Revenue £000 |
Capital £000 |
Total £000 |
Revenue £000 |
Capital £000 |
Total £000 |
|
| Profit before taxation | 129 | 902 | 1,031 | 47 | 802 | 849 |
| Profit before taxation multiplied by standard small company rate of corporation tax in UK of 20% (2012: 20%) |
26 | 180 | 206 | 9 | 160 | 169 |
| Effect of: UK dividends received Non taxable profits on investments Excess management expenses |
(10) – (16) |
– (221) 41 |
(10) (221) 25 |
(5) – (4) |
– (200) 40 |
(5) (200) 36 |
| Tax (credit)/charge | – | – | – | – | – | – |
The Company has no provided, or unprovided, deferred tax liability in either year.
Deferred tax assets in respect of losses have not been recognised as the directors do not currently believe that it is probable that sufficient taxable profits will be available against which the assets can be recovered.
Due to the Company's status as a venture capital trust, and the continued intention to meet the conditions required to comply with Chapter 3 Part 6 of the Income Tax Act 2007, the Company has not provided deferred tax on any capital gains or losses arising on the revaluation or realisation of investments.
Amounts recognised as distributions to equity holders in the period:
| Unaudited 6 months ended 30 June 2013 |
Unaudited 6 months ended 30 June 2012 |
Audited year ended 31 December 2012 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue £000 |
Capital £000 |
Total £000 |
Revenue £000 |
Capital £000 |
Total £000 |
Revenue £000 |
Capital £000 |
Total £000 |
||
| Final paid – 2.5p per ordinary share Paid 5 June 2013 |
154 | 1,001 | 1,155 | – | – | – | – | – | – | |
| Final paid – 2.0p per ordinary share Paid 22 May 2012 |
– | – | – | 341 | 425 | 766 | 294 | 472 | 766 | |
| Interim paid – 2.0p per ordinary share Paid 26 October 2012 |
– | – | – | – | – | – | – | 765 | 765 | |
| Special paid – 0.5p per ordinary share Paid 26 October 2012 |
– | – | – | – | – | – | – | 191 | 191 | |
| 154 | 1,001 | 1,155 | 341 | 425 | 766 | 294 | 1,428 | 1,722 |
An interim dividend of 2.0 pence per ordinary share, amounting to £927,000, is proposed. The dividend has not been recognised in these half year financial statements as the obligation did not exist at the balance sheet date.
The basic and diluted earnings per ordinary share is based on the profit after tax attributable to equity Shareholders of £1,031,000 (30 June 2012: profit of £849,000) and 43,683,833 (30 June 2012: 35,885,606) ordinary shares being the weighted average number of ordinary shares in issue during the period.
The basic and diluted revenue return per ordinary share is based on the revenue profit attributable to equity Shareholders of £129,000 (30 June 2012: £47,000) and 43,683,833 (30 June 2012: 35,885,606) ordinary shares being the weighted average number of ordinary shares in issue during the period.
The basic and diluted capital return per ordinary share is based on the capital profit attributable to equity Shareholders of £902,000 (30 June 2012: profit of £802,000) and 43,683,833 (30 June 2012: 35,885,606) ordinary shares being the weighted average number of ordinary shares in issue during the period.
During the period the Company allotted 254,976 new ordinary shares in respect of its dividend re-investment scheme and 5,038,678 new ordinary shares under the joint offer for subscription with British Smaller Companies VCT plc.
The Company has repurchased 379,961 of its own shares in the period and these shares are held in treasury. The total of 1,632,722 treasury shares has been excluded in calculating the weighted average number of ordinary shares during the period. The Company has no securities that would have a dilutive effect and hence basic and diluted earnings per ordinary share are the same.
The basic and diluted Net Asset Value per ordinary share is calculated on attributable assets of £30,258,000 (30 June 2012 and 31 December 2012: £26,004,000 and £27,152,000 respectively) and 46,371,537 (30 June 2012 and 31 December 2012: 38,243,718 and 41,457,844 respectively) ordinary shares in issue at 30 June 2013.
The 1,632,722 (30 June 2012: 1,178,356) treasury shares have been excluded in calculating the number of ordinary shares in issue at 30 June 2013. The Company has no securities that would have a dilutive effect and hence basic and diluted Net Asset Value per ordinary share are the same.
Total Return per share is calculated on cumulative dividends paid of 37.0 pence per ordinary share (30 June 2012: 32.0 pence per ordinary share and 31 December 2012: 34.5 pence per ordinary share) plus the Net Asset Value as calculated in note 6.
The directors of the Company are: Mr R Last, Mr R M Pettigrew, and Mr P C Waller.
YFM Private Equity Limited ("the Manager") provides fund management, secretarial and administrative services to the Company. Under the management agreement, the Manager receives a fee of 2.5 per cent of the Net Asset Value of the Company up to £16 million, 1.5 per cent of Net Asset Value of the Company in excess of £16 million and up to £26.667 million and 2.0 per cent in respect of any Net Asset Value of the Company in excess of £26.667 million, calculated at half-yearly intervals as at 30 June and 31 December. The effective rate paid to the Fund Manager for the period to 30 June 2013 is 1.8 per cent of the Company's Net Asset Value as at 30 June 2013. Under the same agreement the Manager also provides administrative and secretarial services to the Company for a fee of £46,000 per annum as adjusted for changes in the Retail Price Index. During the period the Company has incurred management fees of £272,000 and secretarial fees of £29,000 payable to the Manager.
Under the terms of the joint offer with British Smaller Companies VCT plc launched on 16 November 2012 (which closed on 30 April 2013), the Manager was entitled to 5.5 per cent of gross subscriptions (before any early investment incentive and re-investment of intermediary commission) for all applications received on or before 28 December 2012. After this date the Manager was entitled to 5.5 per cent of gross subscriptions from execution brokers and 3.5 per cent of gross subscriptions for applications received directly from applicants or through intermediaries offering financial advice. This amounted to £279,491 in total of which £159,591 was received in the six months to 30 June 2013.
The Manager met all costs and expenses arising from these offers out of these fees, including any early investment incentive and any payment or re-investment of initial intermediary commissions (excluding permissible trail commission, which will continue to be met by the Company).
Copies of the interim report can be obtained from the Company's registered office: Saint Martins House, 210-212 Chapeltown Road, Leeds, LS7 4HZ or from the Manager's website: www.yfmep.com
Richard Last Robert Martin Pettigrew Peter Charles Waller
YFM Private Equity Limited Saint Martins House 210-212 Chapeltown Road Leeds LS7 4HZ
hlw Keeble Hawson LLP Protection House 16-17 East Parade
Leeds LS1 2BR
Nplus1 Singer Advisory LLP 1 Bartholomew Lane London EC2N 2AX
Brewin Dolphin Securities Limited 34 Lisbon Street Leeds LS1 4LX
Grant Thornton UK LLP 2 Broadfield Court Sheffield S8 0XF
PricewaterhouseCoopers LLP 1 Embankment Place London WC2N 6RH
Bankers The Royal Bank of Scotland plc 27 Park Row Leeds
LS1 5QB
Lloyds Banking Corporate Markets 40 Spring Gardens Manchester M2 1EN
Company Secretary KHM Secretarial Services Limited Old Cathedral Vicarage St James Row Sheffield S1 1XA
Saint Martins House T: 0113 294 5000 210-212 Chapeltown Road F: 0113 294 5002 Leeds LS7 4HZ E: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.